Intestinal hormones in mesenteric vasodilation after intraduodenal agents.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002766:Cholecystokinin / Q000494:pharmacology*; D004106:Dilatation; D004386:Duodenum / Q000187:drug effects; D005704:Gallbladder / Q000187:drug effects; D005769:Gastrointestinal Motility / Q000187:drug effects; D007441:Intubation, Gastrointestinal; D050356:Lipid Metabolism; D008297:Male; D008638:Mesenteric Arteries / Q000187:drug effects*; D008892:Milk / Q000378:metabolism; D010101:Oxygen Consumption; D010179:Pancreas / Q000187:drug effects; D010649:Phenylalanine / Q000378:metabolism; D012039:Regional Blood Flow / Q000187:drug effects; D012633:Secretin / Q000494:pharmacology*; D014628:Vagotomy; D014655:Vascular Resistance / Q000187:drug effects; D014666:Vasomotor System / Q000187:drug effects*
D012633:Secretin; D010649:Phenylalanine; D001285:Atropine; D002766:Cholecystokinin